A Prospective, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effect of 6-month Acetylcarnitine Therapy on Arterial Blood Pressure, Lipid and Metabolic Profile, and Kidney Function in Hypertensive Patients With Type 2 Diabetes on Background Simvastatin Therapy.
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Levacecarnine (Primary) ; Simvastatin
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Acronyms DIABASI
- 07 Jun 2017 Biomarkers information updated
- 05 Jan 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 25 May 2012 Actual patient number is 229 according to ClinicalTrials.gov.